Dystrophic Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Dystrophic Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A clinical trial update indicates Phase 1/Phase 2 studies are investigating intravenous immunoglobulin–based therapy targeting collagen VII …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Evaluation of D-Fi for the Treatment of Wounds Due to DEB [Phase 3]
This entry reports that Castle Creek Biosciences' Phase 3 trial evaluating D-Fi for treating wounds in Dystrophic Epidermolysis Bullosa is a…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa [Phase 3]
Phase 3 study evaluating KB803 versus matched placebo in Dystrophic Epidermolysis Bullosa is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study [Phase 2]
This is a Phase 2 clinical trial update for TCP-25 Gel in patients with epidermolysis bullosa, including dystrophic and junctional forms. Th…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa [Phase 3]
Phase 3 clinical trial in Japanese patients with epidermolysis bullosa to evaluate the safety and efficacy of Oleogel-S10. Recruitment is on…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Ev.FV for wound healing in patients with dystrophic epidermolysis bullosa is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: MSC EVs in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating mesenchymal stem cell-derived extracellular vesicles (MSC EVs) for dystrophic epidermolysis bull…
-
CLINICAL_TRIALS research · 2025-06-09Clinical Trial Update: Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) [Phase 1, Phase 2]
A clinical trial update evaluating efgartigimod alfa (Vyvgart) to treat bullous diseases by targeting collagen VII antibodies in Epidermolys…